Shamburg News · 8-K filed Oct 28, 2026, 7:14 AM EDT

Enanta Pharmaceuticals Announces CEO Jay Luly Retirement and Names Tara Kieffer Chief Operating Officer

ENTA · ENANTA PHARMACEUTICALS INC

  • Leadership change
  • Reg FD disclosure
  • Materiality: high

On October 28, 2026, Enanta Pharmaceuticals announced that President and CEO Jay R. Luly, Ph.D., age 70, will retire by February 1, 2027, after 23 years of leadership, and will serve as a Strategic Advisor for the remainder of 2027. The Board has begun a search for his successor, considering internal and external candidates. The Company also appointed Tara L. Kieffer, Ph.D., to the newly created role of Chief Operating Officer; she joined Enanta in 2020 and most recently served as Chief Product Strategy Officer.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 5.02, 7.01, 9.01, accession 0001193125-26-435092.

Written from the filing by Shamburg Markets. Figures are as reported by the company.